Yes Lynne, what Joy says is correct. Sof/led has a larger trial base. These are the recommendations from the last EASL conference for treatments for the various genotypes (note the document may not render properly on tablets):

www.easl.eu/medias/cpg/HEPC-2015/Summary.pdf

I'm also 1b and on Sof/dac/Ribavirin. RIBA because of borderline cirrhosis and dac because led wasn't available when I started and I was able to get dac under compassionate access. Frankly, I'd have been perfectly happy with any of the 4 options recommended for 1b. We are now the easiest genotype to cure. The results for both dac and led for 1b's are so close to 100% we really shouldn't waste any energy stressing about the risk of failure (but of course we all do any way!) The fact your disease has not advanced too far gives you even more reason to be extremely confident that at the end of treatment you will be cured.

Have a look at the link in the post at the bottom of the page below Slim:

fixhepc.com/forum/search.html?query=easl...f&childforums=1&ids=

It has all the up-to-date options in it.

This document will help you get an idea of what treatment your doctor is likely to recommend once you have your genotype and fibroscan done.

www.easl.eu/medias/cpg/HEPC-2015/Summary.pdf

This was exactly what my.specialist worked from in determining my treatment given the options then available.

Note that it may not render properly if you're on a tablet. It doesn't on my iPad (it used to which is weird). All the summary boxes are blacked out. They're the bits you want. It's fine on my computer.